The PAD Predicament: A Comprehensive Guide to PAD Risk Factors

Early identification and management of PAD risk factors can help prevent the development and progression of the disease, reducing morbidity and mortality rates (Aboyans et al., 2018).

1. Demographic Risk Factors

Age: The prevalence of PAD increases with age, with the risk rising substantially after the age of 50 (Criqui et al., 2005). Aging is associated with structural and functional changes in the arteries, making them more susceptible to atherosclerosis (Lakatta & Levy, 2003).

Gender: PAD affects both men and women, but the prevalence and severity may differ by gender. Some studies suggest that women may be at a slightly higher risk for PAD, particularly in the presence of other risk factors (Hirsch et al., 2006).

Family history and Genetic Factors: Having a family history of PAD or other cardiovascular diseases increases the risk of developing PAD (Joosten et al., 2012). Additionally, certain genetic factors, such as gene polymorphisms can predispose individuals to PAD [Murabito et. Al, 2012].

Race and ethnicity: PAD prevalence varies among different racial and ethnic groups. African Americans, for example, have a higher risk of developing PAD compared to non-Hispanic whites (Allison et al., 2007).

2. Lifestyle Risk Factors

Smoking and Tobacco Use: Cigarette smoking is a significant risk factor for PAD, with current smokers having a 2-4 times higher risk of developing the disease compared to non-smokers (Lusis, 2000). Tobacco use contributes to endothelial dysfunction and oxidative stress, promoting the development of atherosclerosis (Willigendael et al., 2004).

Physical inactivity: Physical inactivity is associated with an increased risk of PAD. Regular exercise improves cardiovascular health and may help slow the progression of PAD by enhancing endothelial function and reducing inflammation (McDermott et al., 2009).

Obesity: Obesity, particularly abdominal obesity, is a risk factor for PAD. Excess body weight contributes to inflammation and endothelial dysfunction, which can promote atherosclerosis (Selvin et al., 2004).

3. Comorbidities

Diabetes mellitus: Diabetes is a major risk factor for PAD, with diabetic individuals having a 2-4 times higher risk of developing the disease (Alzamora et al., 2008). Hyperglycemia contributes to endothelial dysfunction, oxidative stress, and inflammation, which can accelerate atherosclerosis (Beckman et al., 2002).

Hypertension: Hypertension is associated with an increased risk of PAD. Elevated blood pressure can cause arterial wall injury and contribute to the development of atherosclerosis (Kullo & Rooke, 2006).

Dyslipidemia: Abnormal lipid levels, particularly elevated low-density lipoprotein (LDL) cholesterol and reduced high-density lipoprotein (HDL) cholesterol, are risk factors for PAD. Dyslipidemia contributes to the formation of atherosclerotic plaques in the peripheral arteries (Wilson et al., 1999).

It is crucial to test individuals at high risk for PAD to ensure earlier detection. By raising awareness and promoting proactive measures, we can collectively work towards a healthier future, minimizing the impact of PAD on individuals and the healthcare system at large.

References:

Aboyans, V., Ricco, J. B., Bartelink, M. L. E. L., Björck, M., Brodmann, M., Cohnert, T., … & Fraedrich, G. (2018). Editor’s Choice–2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Journal of Vascular and Endovascular Surgery, 55(3), 305-368.

Alzamora, M. T., Forés, R., Baena-Díez, J. M., Pera, G., Toran, P., & Sorribes, M. (2008). The peripheral arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population. BMC Public Health, 8, 228.

Allison, M. A., Ho, E., Denenberg, J. O., Langer, R. D., Newman, A. B., Fabsitz, R. R., … & Criqui, M. H. (2007). Ethnic-specific prevalence of peripheral arterial disease in the United States. American Journal of Preventive Medicine, 32(4), 328-333.

Beckman, J. A., Creager, M. A., & Libby, P. (2002). Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 287(19), 2570-2581.

Criqui, M. H., Aboyans, V. (2015). Epidemiology of peripheral artery disease. Circulation Research, 116(9), 1509-1526.

Fowkes, F. G., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J. O., McDermott, M. M., … & Criqui, M. H. (2013). Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. The Lancet, 382(9901), 1329-1340.

Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., … & White, C. J. (2006). ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation, 113(11), e463-e654.

Joosten, M. M., Pai, J. K., Bertoia, M. L., Rimm, E. B., Spiegelman, D., Mittleman, M. A., & Mukamal, K. J. (2012). Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA, 308(16), 1660-1667. https://doi.org/10.1001/jama.2012.13415

Kullo, I. J., & Rooke, T. W. (2006). Clinical practice. Peripheral artery disease. The New England Journal of Medicine, 354(5), 1605-1606.

Lakatta, E. G., & Levy, D. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation, 107(1), 139-146.

Lusis, A. J. (2000). Atherosclerosis. Nature, 407(6801), 233-241.

McDermott, M. M., Liu, K., Guralnik, J. M., Martin, G. J., Criqui, M. H., & Greenland, P. (1999). Measurement of walking endurance and walking velocity with

Murabito, J. M., White, C. C., Kavousi, M., Sun, Y. V., Feitosa, M. F., Nambi, V., … & O’Donnell, C. J. (2012). Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circulation: Cardiovascular Genetics, 5(1), 100-112. https://doi.org/10.1161/CIRCGENETICS.111.961292